Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Quantitative Imaging Systems is a private biotechnology and healthcare software company focused on digital imaging microscopy and image analytics for cancer research and drug development. The company develops QiTissue, a software platform that combines cell-based analytics, machine learning, visualization, and multiplex tissue image analysis to help researchers study tumor architecture, immune contexture, and spatial biology. Its tools are positioned for biomedical research, translational research, and drug development workflows rather than as a traditional therapeutic developer. The company has also participated in research projects and grant-supported programs related to cancer imaging, including work connected to NIH LINCS and NCI cancer systems biology efforts. Overall, QI Imaging appears to be a life-science imaging and analytics platform company rather than a drug pipeline company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on QI Imaging.